MENU
APR 21 - 23 2020 Opens: 6:00 AM PT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar

Genetics Virtual Week 2020


LabRoots is excited to announce our 8th Annual Genetics Virtual Week held on April 21-23, 2020!

Genetics Virtual Week 2020 will offer a multi-day content-rich program combining stellar expertise from world-renowned keynote and featured speakers in the areas of Genetics & Genomics an expanding field of biology and human health, Molecular Diagnostics, exploring best laboratory practices and novel diagnostic applications, and Precision Medicine, spanning innovative technologies and solutions transforming healthcare and changing how patients are treated today.  

Over the three days, invited lectures, thought-provoking discussions, and posters will be presented by academia and industry experts, professionals in medical and clinical genetics, scientific leaders, and research scholars.

This years Genetics Virtual Week will include the following topics:

Genetics and Genomics

Genome Editing

  • Latest Genome Editing Techniques and Applications
  • Measuring the Outcomes of Genome Editing Experiments & Characterizing Undesired Editing Effects

The Evolution of Genome Reference Concepts

  • Latest Techniques for Creating Reference-Quality Genomes
  • Analysis and Implications of Pan Genomes

Single Cell and Spatial Genomics

  • Full-length RNA sequencing with Single-Cell Resolution

Structural Variation

  • Latest Methods & Analysis Tools for Characterizing Structural Genomic Variation
  • Structural Genetic Variation in the Global Human Population
  • Implementation of WGS-SV Calling in Monogenic Rare Diseases

Human Genomic Evolution

Molecular Diagnostics

Point of Care Testing

  • Quality
  • Accessibility
  • Cost/Reimbursement
  • Disruptive POC Devices

Emerging Technologies in Molecular Diagnostics

  • Liquid Biopsy
  • CRISPR Diagnostics
  • Digital PCR
  • Omics-based Biomarker Discovery
  • Clinical metagenomics

Artificial Intelligence

  • CDS Tools in Molecular Diagnostics
  • ML based Clinical Algorithms in Cancer Genetics
  • Role of AI in Genomics

Precision Medicine

Rare Disease in Precision Medicine

Precision Medicine in Clinic

  • Next-Generation Sequencing Technologies - The long and the short of it

Molecular Profiling - from Bench to Bedside

 

Our virtual conference allows you to participate in a global setting with no travel or cost to you. The event will remain open 6 months from the date of the live event.  The webinars will be available for unlimited on-demand viewing.  This virtual conference also offers increased reach for the global microbiology community with a high degree of interaction through live-streaming video and chat sessions.

Enjoy the interactive environment via live-streaming video and chat sessions with peers, and using the Leaderboard and Gamification to move around the entire event, earning points for a chance to win one of LabRoots most popular t-shirts.


Call for Posters — Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary and discuss results with interested colleagues through email. Plan now to have your poster included in the 2020 Genetics Virtual Week. Submit your free abstract here.

Continuing Education – LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this event, you can earn 1 Continuing Education credit per presentation for a maximum of 50 credits. This event will also provide CEU's for Genetic Counselors and is pending approval by the NSGC.

Use #LRgenetics to follow the conversation!


Speakers

Show Resources
You May Also Like
APR 29, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 29, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
NOV 12, 2020 6:00 AM PST
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Ten years ago LabRoots launched a new system of learning for a global scientific audience. Now, the 2020 Clinical Diagnostics and Research Virtual Event will again bring together clinicians,...
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
APR 20, 2021 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to announce our 9th Annual Genetics Virtual Week held on April 20-22, 2021! Genetics Virtual Week 2021 will offer a multi-day content-rich program combining stellar exper...
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
SEP 08, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is excited to bring academia and industry, research experts, virologists, microbiologists, healthcare professionals, and leading biomedical scientists under one roof at our 1st Annua...
MAY 06, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 06, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
LabRoots is please to announce our 2nd Forensic Sciences Virtual onMay 6, 2020. The exciting field of forensic sciences is focused on a blend of biology, ch...
MAY 20, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
MAY 20, 2020 6:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Welcome to the 4th Annual Laboratory Automation & Informatics Virtual Event; a free virtual conference for professionals interested in the most recent technologies for today’s labs...
Presentations
Scheduled
  • APR 21, 2020 6:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Advantages of digital PCR and its applications - the power of partitioning
    Daniel Löfgren, MSc.
    Market Development Manager PCR/dPCR EMEA
    Sponsored By: QIAGEN
  • APR 21, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Optimizing human karyomapping to phase single lgene defects with improved DNA amplification
    Samuel Rulli, PhD
    Senior Global Product Manager, RNA Profiling , QIAGEN
    Sponsored By: QIAGEN
The following webinars will be readily on-demand when the event starts
  • Bionano Genome Imaging: unbiased, genome-wide structural variation detection in genetic disease and cancer, down to 1% allele fraction
    Sven Bocklandt, PhD
    Sr. Director of Scientific Affairs & Marketing, Bionano Genomics
  • Contribution of transposons to structural variation and phenotypic diversity in tomato
    Matthias Benoit, PhD
    Research Associate, Lippman Lab, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory
    Continuing Education: Florida CE | P.A.C.E. CE
  • Long HiFi Reads for High-Quality Genome Assemblies
    Jonas Korlach, PhD
    Chief Scientific Officer, Pacific Biosciences
    Continuing Education: Florida CE | P.A.C.E. CE
  • Single cell gene expression: new insights through the lens of full length mRNA isoform resolution
    Jason Underwood, PhD
    Principal Scientist
    Continuing Education: Florida CE | P.A.C.E. CE
  • Spatially Resolved Molecular Investigation of Triple Negative Breast Cancer
    Dina Finan, PhD
    Product Manager, 10x Genomics
    Stephen Williams, PhD
    Senior Computational Biologist, 10x Genomics
  • PRINCESS: A Framework for Comprehensive Detection and Haplotype Phasing of SNPs and Structural Variants
    Medhat Mahmoud, PhD
    Baylor College of Medicine
    Continuing Education: Florida CE | P.A.C.E. CE
Scheduled
The following webinars will be readily on-demand when the event starts
Scheduled
  • APR 23, 2020 7:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: The Massively Parallel Sequencing (MPS) Revolution
    David Smith, PhD
    Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
  • APR 23, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Individualized Health
    Michael Synder, PhD
    Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine
  • APR 23, 2020 10:30 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    Keynote Presentation: Systematic identification of therapeutic strategies that leverage tumor evolution
    Kris Wood
    Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University
    Continuing Education: Florida CE | P.A.C.E. CE
The following webinars will be readily on-demand when the event starts
  • Genomic Landscapes: Leveraging Genetic Evidence throughout the Pharma Pipeline
    Mark Kiel, MD, PhD
    Co-Founder and Chief Science Officer, Genomenon
  • Latest Applications of PacBio Sequencing for Clinical Research
    Jonas Korlach, PhD
    Chief Scientific Officer, Pacific Biosciences
    Continuing Education: Florida CE | P.A.C.E. CE
  • Long-range technologies resolve complex genomic regions overlooked by short-read sequencing
    Mark Ebbert, PhD
    Mayo Clinic
  • Nanotherapeutics: An insight into healthcare and future multi-dimensional clinical applications
    Pratibha Kakadia, PhD
    Research Affiliate, Integrative Behavioural Health Research Institute
  • Population Health and Genetic Testing
    Matthew Ferber, PhD, FACMG
    Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo
    Continuing Education: Florida CE | P.A.C.E. CE
  • Priming the Precision Medicine Pipeline: New Models for Applied Genomics Education
    Barbara Kraatz Fortini, PhD
    Program Director, MS in Human Genetics and Genomic Data Analytics, Assistant Professor of Genetics, School of Pharmacy and Health Sciences at the Keck Graduate Institute
    Continuing Education: Florida CE | P.A.C.E. CE
  • RNA-seq for the Detection of Gene Fusions in Tumors
    Kevin Halling, MD, PhD
    Mayo Clinic
    Continuing Education: Florida CE | P.A.C.E. CE
  • Genomics
    • Single Cell
    • APR 21, 2020 9:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Optimizing human karyomapping to phase single lgene defects with improved DNA amplification
      Samuel Rulli, PhD
      Senior Global Product Manager, RNA Profiling , QIAGEN
      Sponsored By: QIAGEN
    • Single Cell & Spatial Genomics
    • Spatially Resolved Molecular Investigation of Triple Negative Breast Cancer
      Dina Finan, PhD
      Product Manager, 10x Genomics
      Stephen Williams, PhD
      Senior Computational Biologist, 10x Genomics
    • Single Cell and Spatial Genomics
    • Single cell gene expression: new insights through the lens of full length mRNA isoform resolution
      Jason Underwood, PhD
      Principal Scientist
      Continuing Education: Florida CE | P.A.C.E. CE
    • Structural Variation
    • Contribution of transposons to structural variation and phenotypic diversity in tomato
      Matthias Benoit, PhD
      Research Associate, Lippman Lab, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory
      Continuing Education: Florida CE | P.A.C.E. CE
    • PRINCESS: A Framework for Comprehensive Detection and Haplotype Phasing of SNPs and Structural Variants
      Medhat Mahmoud, PhD
      Baylor College of Medicine
      Continuing Education: Florida CE | P.A.C.E. CE
    • Bionano Genome Imaging: unbiased, genome-wide structural variation detection in genetic disease and cancer, down to 1% allele fraction
      Sven Bocklandt, PhD
      Sr. Director of Scientific Affairs & Marketing, Bionano Genomics
    • The Evolution of Genome Reference Concepts
    • Long HiFi Reads for High-Quality Genome Assemblies
      Jonas Korlach, PhD
      Chief Scientific Officer, Pacific Biosciences
      Continuing Education: Florida CE | P.A.C.E. CE
  • Precision Medicine
    • Molecular Profiling - From Bench to Bedside
    • Genomic Landscapes: Leveraging Genetic Evidence throughout the Pharma Pipeline
      Mark Kiel, MD, PhD
      Co-Founder and Chief Science Officer, Genomenon
    • Molecular Profiling - from Bench to Bedside
    • Priming the Precision Medicine Pipeline: New Models for Applied Genomics Education
      Barbara Kraatz Fortini, PhD
      Program Director, MS in Human Genetics and Genomic Data Analytics, Assistant Professor of Genetics, School of Pharmacy and Health Sciences at the Keck Graduate Institute
      Continuing Education: Florida CE | P.A.C.E. CE
    • Precision Medicine in Clinic
    • Latest Applications of PacBio Sequencing for Clinical Research
      Jonas Korlach, PhD
      Chief Scientific Officer, Pacific Biosciences
      Continuing Education: Florida CE | P.A.C.E. CE
    • APR 23, 2020 7:30 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Keynote Presentation: The Massively Parallel Sequencing (MPS) Revolution
      David Smith, PhD
      Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
    • Population Health and Genetic Testing
      Matthew Ferber, PhD, FACMG
      Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo
      Continuing Education: Florida CE | P.A.C.E. CE
    • RNA-seq for the Detection of Gene Fusions in Tumors
      Kevin Halling, MD, PhD
      Mayo Clinic
      Continuing Education: Florida CE | P.A.C.E. CE
    • Long-range technologies resolve complex genomic regions overlooked by short-read sequencing
      Mark Ebbert, PhD
      Mayo Clinic
    • Nanotherapeutics: An insight into healthcare and future multi-dimensional clinical applications
      Pratibha Kakadia, PhD
      Research Affiliate, Integrative Behavioural Health Research Institute
    • APR 23, 2020 10:30 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Keynote Presentation: Systematic identification of therapeutic strategies that leverage tumor evolution
      Kris Wood
      Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University
      Continuing Education: Florida CE | P.A.C.E. CE
    • Rare Disease in Precision Medicine
    • APR 23, 2020 9:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Keynote Presentation: Individualized Health
      Michael Synder, PhD
      Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine
  • Molecular Diagnostics
    • Emerging Technologies in Molecular Diagnostics
    • Precision Infectious Disease Diagnostics Using Next-Generation Sequencing and AI
      Dorottya Nagy-Szakal, MD PhD
      Chief Medical Officer, Biotia, Inc.
      Continuing Education: Florida CE | P.A.C.E. CE
    • APR 21, 2020 6:00 AM PDT
      Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
      Advantages of digital PCR and its applications - the power of partitioning
      Daniel Löfgren, MSc.
      Market Development Manager PCR/dPCR EMEA
      Sponsored By: QIAGEN
  • APR 22, 2020 9:00 AM PDT
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    From Data to Biological Insight using QIAGEN OmicSoft and IPA: Single Cell Sequencing of Normal Human Liver
    Jean-Noel Billaud, PhD
    Principal Scientist, QIAGEN Bioinformatics
    Sponsored By: QIAGEN
    Continuing Education: Florida CE | P.A.C.E. CE
Speakers

  • Michael Synder, PhD
    Stanford Ascherman Professor, Chair of Genetics Director of the Center of Genomics and Personalized Medicine
    Biography
      Michael Snyder is the Stanford Ascherman Professor and Chair of Genetics and the Director of the Center of Genomics and Personalized Medicine. Dr. Snyder received his Ph.D. training at the California Institute of Technology and carried out postdoctoral training at Stanford University. He is a leader in the field of functional genomics and multiomics, and one of the major participants of the ENCODE project. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has developed many technologies in genomics and proteomics. These including the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor (TF) binding sites (ChIP-chip now replaced by ChIP-seq), paired end sequencing for mapping of structural variation in eukaryotes, de novo genome sequencing of genomes using high throughput technologies and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks. Seminal findings from the Snyder laboratory include the discovery that much more of the human genome is transcribed and contains regulatory information than was previously appreciated (e.g. lncRNAs and TF binding sites), and a high diversity of transcription factor binding occurs both between and within species. He has also combined different state-of-the-art "omics" technologies to perform the first longitudinal detailed integrative personal omics profile (iPOP) of person and used this to assess disease risk and monitor disease states for personalized medicine. He is a cofounder of many biotechnology companies, including Excelix, Personalis, SensOmics, Qbio, January, Protos, Oralome, Mirvie and Filtricine.
    • David Smith, PhD
      Professor and Consultant, Department of Laboratory Medicine and Pathology, Mayo Clinic
      Biography
        David I Smith received his Ph.D. in Biochemistry from the University of Wisconsin in Madison in 1978 studying antibiotic resistance in bacteria. After doing post-doctoral work first at the Albert Einstein College of Medicine and then at the University of California, Irvine, he got his first faculty position at Wayne State University in 1985. In 1996 he joined the Mayo Clinic as a full Professor in the Department of Laboratory Medicine and Pathology. His laboratory studies the common fragile sites which are regions of profound genomic instability that are found in all individuals. His laboratory also studies the various ways that human papillomavirus is involved in the generation of different cancers. Dr. Smith is also the Chairman of the Technology Assessment Group for the Mayo Clinic Center for Individualized Medicine. The role of this group is to evaluate new technologies that could have a profound impact on basic research and its' clinical translation. The most exciting technology that has the greatest potential to change both research and clinical practice is next generation sequencing and Dr. Smith and his group have been using this technology to answer scientific questions. The advances in next generation sequencing over the past 10 years have been nothing short of incredible and it is now possible to generate terrabases of DNA sequence in a single run of a next generation sequencer. This technology can be utilized in a number of ways from characterizing just a few genes all the way to whole genome sequencing.
      • Matthias Benoit, PhD
        Research Associate, Lippman Lab, Howard Hughes Medical Institute, Cold Spring Harbor Laboratory
        Biography
          Matthias is an HHMI post-doctoral fellow working in Zach Lippman's group at Cold Spring Harbor Laboratory (New York, USA). He completed a PhD in Molecular Genetics and Physiology with Aline V. Probst at Clermont Auvergne University (France), where he studied histone variants and chromatin dynamics during early seedling development in Arabidopsis. He then joined Jurek Paszowski's group at the Sainsbury Laboratory (University of Cambridge, UK) to characterize transposons subjected to developmental and environmental activation in tomato. Matthias' current and future research aim at understanding the significance of genomic and epigenetic variation in tomato development and breeding.
        • Jean-Noel Billaud, PhD
          Principal Scientist, QIAGEN Bioinformatics
          Biography
            Jean-Noel Billaud, Ph.D. is Principal Scientist at QIAGEN Bioinformatics. He joined Ingenuity Systems (now QIAGEN) in 2008 as staff scientist for in silico research program in oncology and infectious diseases. Jean-Noel Billaud holds a Ph.D. in Blood Cell Biology from Paris VII, and has done his post-doctoral work at the Scripps Research Institute (San Diego, CA).
          • Sven Bocklandt, PhD
            Sr. Director of Scientific Affairs & Marketing, Bionano Genomics
            Biography
              Dr. Sven Bocklandt is a human geneticist with a background in gene discovery. He received his PhD from the University of Antwerp, Belgium, based on research on the genetic components of brain sexual differentiation performed at the National Cancer Institute, and at the University of California Los Angeles. As Director of Scientific Affairs and Marketing at Bionano Genomics, he focuses on the scientific discoveries made on the Bionano platform and on Bionano's performance in genetic disease and cancer diagnostics.
            • Mark Ebbert, PhD
              Mayo Clinic
              Biography
                Dr. Ebbert is an Assistant Professor of Neuroscience at the Mayo Clinic with a background in computational biology and bioinformatics, focusing on Alzheimer's disease, amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD). He is employing long-range technologies to identify functional structural DNA variants and individual RNA isoforms driving disease. Dr. Ebbert also has experience in genomics studies and analyses, algorithm design, and statistics. He has published in respected journals across cancer, bioinformatics, ALS, and Alzheimer's disease.
              • Matthew Ferber, PhD, FACMG
                Associate professor and consultant in the Department of Laboratory Medicine and Pathology, Founder and director of the Clinical Genome Sequencing Laboratory at Mayo
                Biography
                  Dr. Matthew Ferber is an associate professor and consultant in the Department of Laboratory Medicine and Pathology serving as a Co-Director for the Genomics Laboratory since 2005. He was the founder and director of the Clinical Genome Sequencing Laboratory at Mayo from 2012 to 2018. He has worked very closely with Mayo Clinic's Center for Individualized Medicine over the years serving as a founding member of the Clinomics program, which created the Individualized Medicine Clinic and Mayo's Diagnostic Odyssey Services. In October 2018 under the leadership of Dr. Ferber, Mayo's consumer genomic testing product, Mayo Clinic GeneGuideTM, launched.
                • Dina Finan, PhD
                  Product Manager, 10x Genomics
                  Biography
                    Dina Finan is a Product Manager at 10x Genomics. Prior to joining 10x, she worked in the field of protein engineering and antibody stability. She received a Ph.D. in Biochemistry at Stanford University studying molecular motor proteins and their role in embryonic development.
                  • Barbara Kraatz Fortini, PhD
                    Program Director, MS in Human Genetics and Genomic Data Analytics, Assistant Professor of Genetics, School of Pharmacy and Health Sciences at the Keck Graduate Institute
                    Biography
                      Barbara Fortini is Assistant Professor of Genetics and Program Director for the new Master of Science in Human Genetics and Genomic Data Analytics (MSGDA) Program in the School of Pharmacy and Health Sciences at the Keck Graduate Institute, one of the Claremont Colleges in Claremont, CA. Barbara completed her PhD at the California Institute of Technology where her thesis focused on the biochemistry and genetics of genome stability. Barbara undertook her postdoctoral training at the University of Southern California - Keck School of Medicine in the department of Preventive Medicine using post-GWAS functional genomics to understand colorectal cancer risk. Upon her appointment as Assistant Professor of Genetics in KGI's School of Pharmacy and Health Sciences, she worked closely alongside Ashley Mills, Program Director of the new MS in Genetic Counseling, to launch both genetics masters programs in the Fall of 2018. Barbara currently teaches courses in Human Molecular Genetics, Human Genomics with NGS Lab, and Functional Genomics for both programs.
                    • Kevin Halling, MD, PhD
                      Mayo Clinic
                      Biography
                        Dr. Halling is a molecular pathologist and a Professor in the Division of Laboratory Genetics. He is a co-director of the Genomics Laboratory which performs molecular oncology and hereditary disorder testing. He received his M.D. and Ph.D. from the University of Kansas and completed an Anatomic and Clinical pathology residency and Clinical Molecular Genetics fellowship at the Mayo Clinic. His primary area of interest is in the development of genetic tests that can be used for the diagnosis and treatment of sporadic and hereditary cancer. He and his team have developed a clinical RNA Seq assay that can be used to detect gene fusions in patients with various types of malignancies and are also working on other clinical applications of RNA-seq and other RNA testing methodologies. Dr. Halling has published over 100 papers that mostly relate to genetic testing of cancer.
                      • Pratibha Kakadia, PhD
                        Research Affiliate, Integrative Behavioural Health Research Institute
                        Biography
                          Pratibha Kakadia received her PhD in Pharmaceutical Science from University of Huddersfield, England, UK. Her graduate research was completed in the lab of Prof. Barbara Conway, Ph.D. Her research is focussed on the investigation of design and development of nanoformulations for the targeted delivery of antibacterial drugs for treatment of skin infections. She has worked as Scientist in Merck Research Labs in Pennsylvania, supporting formulation of RNA based lipid nanoparticles delivery for preclinical research. Currently, Pratibha is the Research Affiliate with Integrative Behavioural Health Research Institute, Pasadena, California. She has three-first author publications in the reputed peer-reviewed journals and 2 oral and 10 poster talks on the design and formulation of lipid nanoparticles approach for controlled and targeted drug delivery.
                        • Mark Kiel, MD, PhD
                          Co-Founder and Chief Science Officer, Genomenon
                          Biography
                            Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was more likely to emerge out of industry. In 2014, he founded Genomenon - a life science IT company addressing the challenge of connecting doctors with evidence in the literature to help diagnose patients with genetic diseases and cancer.
                          • Jonas Korlach, PhD
                            Chief Scientific Officer, Pacific Biosciences
                            Biography
                              Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He co-invented the SMRT technology with Stephen Turner, Ph.D., Pacific Biosciences Founder and Chief Technology Officer, when the two were graduate students at Cornell University. Dr. Korlach joined Pacific Biosciences as the company's eighth employee in 2004. Previously, he was a Postdoctoral Researcher at Cornell University. Dr. Korlach is the recipient of multiple grants, an inventor on 70 issued U.S. patents and 61 international patents, and an author of over 100 scientific studies on the principles and applications of SMRT technology, including publications in Nature, Science, and PNAS. In 2013, Dr. Korlach was honored by the Obama White House as an Immigrant Innovator "Champion of Change." He received both his Ph.D. and his M.S. degrees in Biochemistry, Molecular and Cell Biology from Cornell, and received M.S. and B.A. degrees in Biological Sciences from Humboldt University in Berlin, Germany.
                            • Daniel Löfgren, MSc.
                              Market Development Manager PCR/dPCR EMEA
                              Biography
                                Daniel Heinz Löfgren is the Market Development Manager for digital PCR (dPCR) and PCR at QIAGEN for EMEA. He has over 10 years of experience in the field of PCR, qPCR and dPCR, with assay design, different workflows and applications. In addition, he has worked for 5 years as a Field Applications Specialist for droplet digital PCR and qPCR. Furthermore, he has experience working as a Genomics Applications Specialist supporting QIAGEN's NGS workflows.
                              • Medhat Mahmoud, PhD
                                Baylor College of Medicine
                                Biography
                                  Degree: Ph.D. in Biochemistry, Institute of Bioorganic Chemistry, Polish Academy of Science, Poznań, Poland. Postdoc fellow in Human Genome Sequencing Center, Baylor College of Medicine... Interests: I'm interested in studying genomic variants and their effect, including the development of tools for comprehensive variant analysis (SNVs, SVs, and Methylation).
                                • Dorottya Nagy-Szakal, MD PhD
                                  Chief Medical Officer, Biotia, Inc.
                                  Biography
                                    Dorottya earned her MD and PhD in clinical medicine from Semmelweis University of Medicine in Hungary. Holding postdoctoral fellowships at Baylor College of Medicine/Texas Children's Hospital and Columbia University, she has 10+ years of experience in translational medicine, pediatrics, gastroenterology, microbiology, and clinical metagenomics. She led cutting-edge clinical trials on fecal microbiome transplantation and developed a multicenter research program to understand the role of the gut-brain axis in the integrative neuroscience field. Currently, Dorottya is the Chief Medical Officer at Biotia, a NYC-based startup focusing on rapid infectious disease diagnostics, surveillance, and prevention of hospital-acquired infections powered by artificial intelligence.
                                  • Samuel Rulli, PhD
                                    Senior Global Product Manager, RNA Profiling , QIAGEN
                                    Biography
                                      Samuel Rulli is a Senior Global Product Manager for the QIAseq RNA Profiling Technologies at QIAGEN. Dr. Rulli received his Ph.D. in 2002 from Tulane University studying the gastric proton pump and did post-doctoral research at Johns Hopkins University and the National Cancer Institute in Frederick, MD. He joined SABiosciences - now a part of QIAGEN - in 2007 as an R&D Scientist in qPCR applications and moved to a Global Product Manager role in 2014. Trained as a molecular biologist, Dr. Rulli has worked on different assay detection technologies for gene expression and nucleic acid analysis.
                                    • Jason Underwood, PhD
                                      Principal Scientist
                                      Biography
                                        Jason G. Underwood, Ph.D is Principal Scientist for PacBio, specializing in molecular biology. After doctoral and postdoctoral training in RNA biology, Dr. Underwood joined PacBio in 2010 and developed the first protocols for PacBio's long read RNA-seq product known as Iso-Seq or isoform sequencing to read full length mRNAs. More recently, he has focused on technology development, adapting the Iso-Seq methods to target specific gene families or to capture full length mRNA sequences with single cell resolution.
                                      • Stephen Williams, PhD
                                        Senior Computational Biologist, 10x Genomics
                                        Biography
                                          Stephen Williams is a Senior Computational Biologist at 10x Genomics. Prior to joining 10x Genomics, she was an Assistant Professor at University of Virginia. He received a Ph.D. in Human and Molecular Genetics at Virginia Commonwealth University where he studied the genomic and molecular causes of intellectual disability syndromes such as Smith-Magenis Syndrome.
                                        • Kris Wood
                                          Assistant Professor, Department of Pharmacology and Cancer Biology, Duke University
                                          Biography
                                            Kris C. Wood, Ph.D., is an Associate Professor in the Department of Pharmacology and Cancer Biology at Duke University. He received his B.S. degree in Chemical Engineering from the University of Kentucky, where he was recognized with the outstanding sophomore, junior, and senior awards in Chemical Engineering, the Tau Beta Pi outstanding senior award in the College of Engineering, and a Barry M. Goldwater scholarship in science and mathematics. He received his Ph.D. in Chemical Engineering from the Massachusetts Institute of Technology, where he developed self-assembling polymeric systems for controlled gene and drug delivery under the supervision of Professors Paula Hammond, Ph.D. and Robert Langer, Sc.D. As an NIH and Misrock Fund postdoctoral fellow in the laboratory of David Sabatini, M.D., Ph.D. at the Whitehead Institute for Biomedical Research and the Broad Institute of Harvard and MIT, his work focused on the development of functional genomic tools to study the determinants of anticancer drug sensitivity. Kris' lab at Duke, founded in 2012, focuses on two related themes: (1) identifying, mechanistically characterizing, and translating new, molecularly targeted therapeutic strategies for biomarker-defined cancer subtypes and (2) defining rational strategies to control long term tumor evolution. To power these studies, Kris' team develops and adapts a range of new functional genomic technologies. The lab's work has been recognized by early career awards from the Ovarian Cancer Research Fund Alliance, the V Foundation, the Stewart Trust, the Forbeck Foundation, the Whitehead Foundation, and the NIH BIRCWH Program. It has also inspired the design of multiple ongoing clinical trials and the creation of three biotechnology companies: Celldom (Silicon Valley, CA), Tavros Therapeutics (Durham, NC), and Element Genomics, now a wholly owned subsidiary of UCB Pharma (Brussels).
                                          Sponsored by

                                          For information on becoming a sponsor or exhibitor, please click here.


                                          Posters

                                          Posters

                                           

                                          POSTER SUBMISSION GUIDELINES

                                          Virtual poster sessions offer the opportunity to present data to a global audience via a PDF poster and video summary, and discuss results with interested colleagues through email. Posters should be submitted as a PowerPoint file. Presentations should incorporate illustrative materials such as tables, graphs, photographs, and large-print text. This content is not peer-reviewed. Submission is free.  If you are interested in sponsoring a Poster for this virtual event and generate leads, the cost is $250 and you can submit the poster at advertise@labroots.com.


                                          SUBMIT YOUR ABSTRACT

                                          Enter the following information to this Submission Form:

                                          • Poster Title
                                          • Your Name
                                          • Your Institution
                                          • Your Email
                                          • Abstract describing the poster


                                          All submitted abstracts will be reviewed and decisions regarding acceptance will be made as abstracts are received. You will be notified within one week of receipt about acceptance. Further details and registration materials will be provided at that time. You do not have to be present in order to have a poster displayed. Only those abstracts approved by LabRoots may display posters at this event.

                                          If accepted, you will also have the opportunity to record a 3-5 minute summary video for each poster. LabRoots will work with each individual to create these videos. Video links and email contact information will be included on each poster displayed.

                                          Questions? Email Posters@LabRoots.com

                                          LabRoots Policy

                                          C.E. Credits

                                          The speakers below have been approved for CME, CE, or CEU credits. To redeem your credits, locate the presentation you watched and click on the CME/CE/CEU buttons for further direction. For more general information regarding continuing education, the processes to receive credits, and the accreditation bodies, Click here


                                          Committee

                                          To download the Program Committee brochure here.


                                          • Shawn Baker

                                            Dr. Shawn C. Baker is the Chief Science Officer and co-founder of AllSeq. Having received his Ph.D. at the University of California - Davis, he started his career as a Research Scientist at Illumina when it was a 15-person startup. After spending several years at the bench ...

                                            See more See less
                                          • Agnieszka Caruso

                                            Agnieszka is currently a Staff Scientist and Laboratory Manager at TessArae, LLC in Sterling, VA, USA. She obtained her PhD at the University of Queensland in Australia in a field of biochemistry, and subsequently worked as a post-doctoral fellow at Queen's University of Belfast ...

                                            See more See less
                                          • Bryan Cobb

                                            Dr. Cobb is the acting Director for Clinical Molecular Diagnostics at Roche Diagnostics Corporation where he serves in a scientific advisory role supporting the laboratory scientific community. He obtained his Ph.D. in Medical Genetics at the University of Alabama at Birmingham ...

                                            See more See less
                                          • Sarah Elsea

                                            Dr. Sarah H. Elsea is an Associate Professor of Molecular and Human Genetics at Baylor College of Medicine and is Senior Division Director of Biochemical Genetics at Baylor Genetics. Dr. Elsea earned a B.S. in chemistry from Missouri State University and Ph.D. in biochemistry ...

                                            See more See less
                                          • Emily Hollister

                                            Dr. Emily Hollister is a microbial ecologist and serves as the Vice President for Information Technology & Analytics at Diversigen, Inc. Prior to joining Diversigen, Dr. Hollister served as an Assistant Professor in the Department of Pathology & Immunology at Baylor College of ...

                                            See more See less
                                          • Eugean Jiwanmall

                                            Eugean Jiwanmall's past professional experiences include basic science and clinical research. In his current role as a Senior Research Analyst for Medical Policy & Technology Evaluation at Independence Blue Cross' Claim Payment Policy Department within Facilitated Health ...

                                            See more See less
                                          • Mark Kiel, PhD

                                            Dr. Mark Kiel is Co-Founder and Chief Science Officer at Genomenon, where he oversees the company's scientific direction and product development. After spending 15 years preparing for a life of academic research, Mark became convinced that revolutionary change in genomics was ...

                                            See more See less
                                          • Jonas Korlach

                                            Jonas Korlach was appointed Chief Scientific Officer of Pacific Biosciences in July 2012. He was previously a Scientific Fellow, supporting commercial development of the PacBio RS II system and performing research aimed at developing new applications for SMRT technologies. He ...

                                            See more See less
                                          • Tatjana Matejic

                                            Tatjana is an immunologist with more than two decades of experience working at biotech and pharma companies from start-ups to large global corporations ( Pfizer,Inc. being the latest), contributing significantly to team efforts and successes of more than thirty early and clinical ...

                                            See more See less
                                          • Molly McGinniss

                                            Molly McGinniss, MS, LCGC is a Senior Market Development Manager for Illumina's "Healthy Genome Initiatives" team. Her current role focuses on advancing the use of whole genome sequencing in clinical care by providing access and education to healthy individuals through the ...

                                            See more See less
                                          • John Quackenbush

                                            John Quackenbush is Professor of Computational Biology and Bioinformatics and Chair of the Department of Biostatistics at the Harvard TH Chan School of Public Health and Professor of Biostatistics and Computational Biology at the Dana-Farber Cancer Institute. John's PhD was in ...

                                            See more See less
                                          • Fritz Sedlazeck

                                            Dr. Fritz Sedlazeck completed his PhD in 2012 in the group of Dr. Arndt von Haeseler at the Max F. Perutz Laboratory in Vienna. After a two year postdoc, he transitioned to the lab of Dr. Michael Schatz at Cold Spring Harbor Laboratory and later to Johns Hopkins University. Since ...

                                            See more See less
                                          • Khyati Shah

                                            Khyati Shah received her Ph.D. in Molecular Pharmacology from the University of the Pacific, Stockton, California. Her graduate research was completed in the lab of Jesika Faridi, Ph.D. Her work focused on the investigation of the mechanism of Akt induced tamoxifen resistance in ...

                                            See more See less
                                          • David Smith, PhD

                                            David I Smith received his B.S. in Mathematics and Molecular Biology from the University of Wisconsin in Madison. He then received his Ph.D. for the Department of Biochemistry also at the University of Wisconsin in Madison. After several postdoctoral positions he got his first ...

                                            See more See less
                                          • Tao Wu

                                            Dr. Tao Wu received his B.S. from Nankai University a leading academic institution in China. In his last year at college, his reading of "What Is Life? The Physical Aspect of the Living Cell" (by physicist Erwin Schrödinger, 1944) inspired him to pursue a career in deciphering ...

                                            See more See less
                                          Help

                                          General LabRoots Questions

                                          email support@labroots.com  

                                          Virtual Events and Webinars

                                          Supported Configurations

                                          • Operating System Internet Explorer Firefox Chrome Safari
                                            Vista IE8+ FF10+ Chrome15+
                                            Windows 7 IE8+ FF10+ Chrome15+
                                            Windows 8 IE10 FF10+ Chrome15+
                                            Mac OS X   FF10+ Chrome15+ Safari5.1+
                                          • Cookie settings: session cookies enabled
                                          • Browser configuration must have JavaScript enabled
                                          • Adobe Flash player 10.2 or later

                                          To watch our webinars and virtual events a modern browser such as Chrome, Firefox, Safari, or an updated version of Internet Explorer is required.

                                          Internet Connection

                                          • A minimum of 100Kbps is recommended for audio-only events
                                          • A minimum of 300Kbps is recommended for speaker on-video events

                                          Computer Equipment

                                          • Screen Resolution: Minimum 1024x768
                                          • Video Card: 65,000 colors minimum
                                          • Sound card and speakers (or headphones) for hearing webcast in full format
                                          • Audio Card: 16-bit minimum
                                          • RAM: 512MB of free RAM

                                          Firewall Protocol

                                          • HTTP on port 80 or HTTPS on port 443
                                          • Adobe RTMP on port 1935, 80, or 443 with automatic fall-back to RTMPT (RTMP tunneling) on ports 1935, 80 or 443
                                          • RTMPE (RTMP encrypted) on ports 1935, 80 or 443

                                          Work-At-Home Attendees

                                          • If a corporate VPN is used, confirm that your network traffic is not directed over the company VPN. If it is, please turn off the VPN while attending the virtual event.

                                          For A Seamless Experience

                                          When using a mobile device, FREE Mobile Apps are available:

                                          - For viewing Webinars:

                                          - For viewing Virtual Events

                                          Attendee Guide

                                          • To learn more about how the virtual event works for attendees, download the Attendee Guide (PDF).

                                          Virtual Event and Webinar Support:

                                          Continuing Education (CME/CE) Support

                                          Loading Comments...
                                          Show Resources
                                          Event Countdown
                                          • 0 Days
                                          • 0 Hours
                                          • 0 Minutes
                                          • 0 Seconds